Patents by Inventor Charlotta Enerback

Charlotta Enerback has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Psoriasin expression by breast epithelial cells
    Patent number: 7776541
    Abstract: The invention features methods of diagnosing high grade ductal carcinoma in situ (DCIS) These methods involve measuring: (1) the level of HID-5 in a body fluid (e.g., blood or urine) of a subject suspected of having, or at risk of having, high grade DCIS; or (2) the level of HID-5 gene expression in breast tissue from a subject suspected of having, or at risk of having, high grade DCIS. The invention also embodies a method of inhibiting expression of HID-5 protein in DCIS cells and methods of treating a subject suspected of having, or at risk of having, high grade DCIS.
    Type: Grant
    Filed: December 8, 2008
    Date of Patent: August 17, 2010
    Assignee: Dana-Faber Cancer Institute, Inc.
    Inventors: Kornelia Polyak, Charlotta Enerback
  • Psoriasin Expression By Breast Epithelial Cells
    Publication number: 20090104618
    Abstract: The invention features methods of diagnosing high grade ductal carcinoma in situ (DCIS) These methods involve measuring: (1) the level of HID-5 in a body fluid (e.g., blood or urine) of a subject suspected of having, or at risk of having, high grade DCIS; or (2) the level of HID-5 gene expression in breast tissue from a subject suspected of having, or at risk of having, high grade DCIS. The invention also embodies a method of inhibiting expression of HID-5 protein in DCIS cells and methods of treating a subject suspected of having, or at risk of having, high grade DCIS.
    Type: Application
    Filed: December 8, 2008
    Publication date: April 23, 2009
    Applicant: DANA-FARBER CANCER INSTITUTE, INC.
    Inventors: Kornelia Polyak, Charlotta Enerback
  • Psoriasin expression by breast epithelial cells
    Patent number: 7465553
    Abstract: The invention features methods of diagnosing high grade ductal carcinoma in situ (DCIS) These methods involve measuring: (1) the level of HID-5 in a body fluid (e.g., blood or urine) of a subject suspected of having, or at risk of having, high grade DCIS; or (2) the level of HID-5 gene expression in breast tissue from a subject suspected of having, or at risk of having, high grade DCIS. The invention also embodies a method of inhibiting expression of HID-5 protein in DCIS cells and methods of treating a subject suspected of having, or at risk of having, high grade DCIS.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: December 16, 2008
    Assignee: Dana-Farber Cancer Institute, Inc.
    Inventors: Kornelia Polyak, Charlotta Enerbäck
  • Psoriasin expression by breast epithelial cells
    Publication number: 20030138833
    Abstract: The invention features methods of diagnosing high grade ductal carcinoma in situ (DCIS) These methods involve measuring: (1) the level of HID-5 in a body fluid (e.g., blood or urine) of a subject suspected of having, or at risk of having, high grade DCIS; or (2) the level of HID-5 gene expression in breast tissue from a subject suspected of having, or at risk of having, high grade DCIS. The invention also embodies a method of inhibiting expression of HID-5 protein in DCIS cells and methods of treating a subject suspected of having, or at risk of having, high grade DCIS.
    Type: Application
    Filed: December 30, 2002
    Publication date: July 24, 2003
    Inventors: Kornelia Polyak, Charlotta Enerback